首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
【24h】

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

机译:通过蛋白质芯片对疟疾季节前后疟原虫对抗体的Ab反应进行前瞻性分析

获取原文
获取原文并翻译 | 示例
       

摘要

Abs are central to malaria immunity, which is only acquired after years of exposure to Plasmodium falciparum (Pf). Despite the enormous worldwide burden of malaria, the targets of protective Abs and the basis of their inefficient acquisition are unknown. Addressing these knowledge gaps could accelerate malaria vaccine development. To this end, we developed a protein microarray containing ~23% of the Pf 5,400-protein proteome and used this array to probe plasma from 220 individuals between the ages of 2-10 years and 18-25 years in Mali before and after the 6-month malaria season. Episodes of malaria were detected by passive surveillance over the 8-month study period. Ab reactivity to Pf proteins rose dramatically in children during the malaria season; however, most of this response appeared to be short-lived based on cross-sectional analysis before the malaria season, which revealed only modest incremental increases in Ab reactivity with age. Ab reactivities to 49 Pf proteins measured before the malaria season were significantly higher in 8-10-year-old children who were infected with Pf during the malaria season but did not experience malaria (n = 12) vs. those who,experienced malaria (n = 29). This analysis also provided insight into patterns of Ab reactivity against Pf proteins based on the life cycle stage at which proteins are expressed, subcellular location, and other proteomic features. This approach, if validated in larger studies and in other epidemiological settings, could prove to be a useful strategy for better understanding fundamental properties of the human immune response to Pf and for identifying previously unde-scribed vaccine targets.
机译:Abs是疟疾免疫力的核心,只有在暴露于恶性疟原虫(Pf)后多年才能获得。尽管全世界范围内都有巨大的疟疾负担,但尚不知道保护性Abs的目标及其低效获取的基础。解决这些知识鸿沟可能会加速疟疾疫苗的开发。为此,我们开发了一种蛋白质微阵列,包含〜23%的Pf 5,400蛋白蛋白质组,并用该阵列探测了6个前后马里2-10岁至18-25岁年龄段的220个人的血浆月疟疾季节。在8个月的研究期内,通过被动监测发现了疟疾发作。在疟疾季节,儿童对Pf蛋白的抗体反应性急剧上升。然而,根据疟疾季节之前的横断面分析,大多数这种反应似乎是短暂的,这表明随着年龄的增长,Ab反应性只会适度增加。与经历过疟疾的儿童相比,在疟疾季节被Pf感染但未经历过疟疾(n = 12)的8-10岁儿童中,对疟疾季节之前测得的49 Pf蛋白的Ab反应性显着更高。 n = 29)。该分析还根据蛋白质表达的生命周期阶段,亚细胞定位和其他蛋白质组学特征,提供了针对Ab对Pf蛋白质反应性模式的见解。如果在更大的研究和其他流行病学环境中得到验证,该方法将被证明是一种有用的策略,可用于更好地了解人类对Pf的免疫反应的基本特性以及鉴定以前未描述的疫苗靶标。

著录项

  • 来源
  • 作者单位

    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

    School of Information and Computer Sciences, Institute for Genomics and Bioinformatics, University of California, Irvine, CA 92697;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

    Antigen Discovery, Inc., Irvine, CA 92618;

    Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA 92697;

    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

    Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA 92697;

    Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA 92697;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

    Antigen Discovery, Inc., Irvine, CA 92618;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali;

    Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852 Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

    Molecular Vaccinology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia;

    School of Information and Computer Sciences, Institute for Genomics and Bioinformatics, University of California, Irvine, CA 92697;

    Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Dentistry, University of Bamako, Bamako BP 1805, Mali Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA 92697;

    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    antigen discovery; naturally acquired immunity; plasmodium falciparum malaria; prospective cohort study; mali;

    机译:抗原发现;自然获得的免疫力;恶性疟原虫疟疾;前瞻性队列研究;马里;
  • 入库时间 2022-08-18 00:41:21

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号